Search Results - "Kawaoka T"

A Multicenter Phase II Study on Atezolizumab plus Bevacizumab Combination Therapy in Patients with Unresectable Hepatocellular Carcinoma and Child-Pugh Classification B Cirrhosis: CHALLENGE Trial.

Authors: Terashima T Ikeda M Yamashita T et al.

Source: Liver cancer [Liver Cancer] 2026 Mar 12. Date of Electronic Publication: 2026 Mar 12.

Publication Type: Journal Article

Journal Info: Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101597993 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2235-1795 (Print) Linking ISSN: 16645553 NLM ISO Abbreviation: Liver Cancer

Anlotinib plus penpulimab: a new contender in first-line therapy for unresectable hepatocellular carcinoma.

Authors: Ono A Hayes CN Kawaoka T et al.

Source: Journal of gastrointestinal oncology [J Gastrointest Oncol] 2026 Apr 30; Vol. 17 (2), pp. 114. Date of Electronic Publication: 2026 Apr 28.

Publication Type: Editorial; Comment

Journal Info: Publisher: AME Publishing Group Country of Publication: China NLM ID: 101557751 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2078-6891 (Print) Linking ISSN: 20786891 NLM ISO Abbreviation: J Gastrointest Oncol Subsets: PubMed not MEDLINE

Intracellular enhancement technique for gadoxetic acid-enhanced hepatobiliary-phase magnetic resonance imaging: evaluation of hepatic function.

Authors: Fonseca D Nakamura Y Higaki T et al.

Source: Abdominal radiology (New York) [Abdom Radiol (NY)] 2025 Aug; Vol. 50 (8), pp. 3506-3515. Date of Electronic Publication: 2025 Jan 31.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101674571 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2366-0058 (Electronic) NLM ISO Abbreviation: Abdom Radiol (NY) Subsets: MEDLINE

Comparison of outcomes of second-line durvalumab plus tremelimumab versus lenvatinib following first-line atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.

Authors: Nishioka, Chinatsu Tahata, Yuki Maesaka, Kazuki et al.

Source: PLoS ONE. 5/7/2026, Vol. 21 Issue 5, p1-14. 14p.

Reply from the authors.

Authors: Kawaoka T Ando Y Yamauchi M et al.

Source: Hepatology research : the official journal of the Japan Society of Hepatology [Hepatol Res] 2020 Dec; Vol. 50 (12), pp. 1393.

Publication Type: Letter

Journal Info: Publisher: Blackwell Publishing Country of Publication: Netherlands NLM ID: 9711801 Publication Model: Print Cited Medium: Print ISSN: 1386-6346 (Print) Linking ISSN: 13866346 NLM ISO Abbreviation: Hepatol Res Subsets: PubMed not MEDLINE

Usefulness of serum HBV RNA levels for predicting antiviral response to entecavir treatment in patients with chronic hepatitis B.

Authors: Kosaka M Fujino H Tsuge M et al.

Source: Journal of gastroenterology [J Gastroenterol] 2025 Apr; Vol. 60 (4), pp. 469-478. Date of Electronic Publication: 2025 Jan 22.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer International Country of Publication: Japan NLM ID: 9430794 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-5922 (Electronic) Linking ISSN: 09441174 NLM ISO Abbreviation: J Gastroenterol Subsets: MEDLINE

Atezolizumab plus Bevacizumab with Transcatheter Arterial Chemoembolization (Sandwich Strategy) versus Atezolizumab plus Bevacizumab Alone in Hepatocellular Carcinoma: A Multicenter Retrospective Study.

Authors: Hashimoto K Kawaoka T Emori T et al.

Source: Liver cancer [Liver Cancer] 2025 Dec 09. Date of Electronic Publication: 2025 Dec 09.

Publication Type: Journal Article

Journal Info: Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101597993 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2235-1795 (Print) Linking ISSN: 16645553 NLM ISO Abbreviation: Liver Cancer

Postoperative supplementation with high-titer pancreatic enzymes and zinc acetate dihydrate could reduce the risk of liver fat deposition, especially in patients with severe remnant pancreatic atrophy after pancreaticoduodenectomy: a retrospective study.

Authors: Matsukuma S Kinjo N Suzuki A et al.

Source: BMC surgery [BMC Surg] 2025 Nov 05; Vol. 25 (1), pp. 527. Date of Electronic Publication: 2025 Nov 05.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968567 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2482 (Electronic) Linking ISSN: 14712482 NLM ISO Abbreviation: BMC Surg Subsets: MEDLINE

Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma.

Authors: Miura R Ono A Nakahara H et al.

Source: Journal of gastroenterology [J Gastroenterol] 2025 Mar; Vol. 60 (3), pp. 328-339. Date of Electronic Publication: 2024 Dec 09.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer International Country of Publication: Japan NLM ID: 9430794 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-5922 (Electronic) Linking ISSN: 09441174 NLM ISO Abbreviation: J Gastroenterol Subsets: MEDLINE

Pharmacist intervention through protocol-based pharmacotherapy management is effective to ensure safety in invasive procedures for chronic liver disease.

Authors: Shibata Y Koga Y Sato Y et al.

Source: Journal of pharmaceutical health care and sciences [J Pharm Health Care Sci] 2025 Aug 14; Vol. 11 (1), pp. 74. Date of Electronic Publication: 2025 Aug 14.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101672177 Publication Model: Electronic Cited Medium: Print ISSN: 2055-0294 (Print) Linking ISSN: 20550294 NLM ISO Abbreviation: J Pharm Health Care Sci Subsets: PubMed not MEDLINE

A novel approach to evaluate the therapeutic efficacy of durvalumab and tremelimumab combination therapy in hepatocellular carcinoma.

Authors: Tomonari, Tetsu Shimose, Shigeo Saeki, Issei et al.

Source: Hepatology Research. Aug2025, Vol. 55 Issue 8, p1184-1192. 9p.

Efficacy of Lenvatinib as Second-Line Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma.

Authors: Takizawa, Daichi Arai, Hirotaka Shibasaki, Mitsuhiko et al.

Source: Current Oncology. Mar2026, Vol. 31 Issue 3, p159. 12p.

A prospective observational study of laparoscopic approaches for suspected gallbladder cancer in Yamaguchi (YPB-002 LAGBY).

Authors: Tokumitsu Y Kawaoka T Matsukuma S et al.

Corporate Authors: Tokumitsu Y Kawaoka T Matsukuma S et al.

Source: Updates in surgery [Updates Surg] 2025 Apr; Vol. 77 (2), pp. 435-445. Date of Electronic Publication: 2025 Feb 24.

Publication Type: Journal Article; Observational Study

Journal Info: Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 101539818 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2038-3312 (Electronic) Linking ISSN: 2038131X NLM ISO Abbreviation: Updates Surg Subsets: MEDLINE

Cost-utility analysis of lenvatinib and sorafenib for the first-line treatment of unresectable hepatocellular carcinoma in Vietnam: Evidence from a lower-middle income country.

Authors: Do, Thang Xuan Nguyen, Ha Thi Nguyen, Phuong Thi Lan et al.

Source: PLoS ONE. 4/3/2026, Vol. 21 Issue 4, p1-13. 13p.

Clinical Characteristics, Surgical Management and Outcomes of Sciatic Scoliosis Secondary to Lumbar Disc Herniation: A Systematic Review.

Authors: Fava, Marco Mendola, Elena Perna, Fabrizio et al.

Source: Life (2075-1729). Apr2026, Vol. 16 Issue 4, p589. 17p.

Sorafenib-treated hepatocellular carcinoma with or without prior direct-acting antiviral therapy for hepatitis C: outcomes and survival.

Authors: Lithy, Rania Kohla, Mohamed Dabees, Hossam et al.

Source: Egyptian Liver Journal. 8/16/2025, Vol. 15 Issue 1, p1-11. 11p.

Impact of viral eradication by direct-acting antivirals on clinical outcomes after curative treatment for hepatitis C virus-associated hepatocellular carcinoma.

Authors: Nagaoki Y Yamaoka K Fujii Y et al.

Source: Therapeutic advances in gastroenterology [Therap Adv Gastroenterol] 2025 Mar 12; Vol. 18, pp. 17562848251324094. Date of Electronic Publication: 2025 Mar 12 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Sage Publications Country of Publication: England NLM ID: 101478893 Publication Model: eCollection Cited Medium: Print ISSN: 1756-283X (Print) Linking ISSN: 1756283X NLM ISO Abbreviation: Therap Adv Gastroenterol Subsets: PubMed not MEDLINE

Prognostic impact and risk factors of severe neutropenia in the early phase of treatment with trifluridine-tipiracil for metastatic colorectal cancer patients: a single-center retrospective study.

Authors: Omori Y Matsukuma S Kawa M et al.

Source: International journal of colorectal disease [Int J Colorectal Dis] 2025 Jan 13; Vol. 40 (1), pp. 11. Date of Electronic Publication: 2025 Jan 13.

Publication Type: Journal Article

Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 8607899 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1262 (Electronic) Linking ISSN: 01791958 NLM ISO Abbreviation: Int J Colorectal Dis Subsets: MEDLINE

No Correlation Between Proteinuria and Renal Function in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: ARISE Study †.

Authors: Ueshima, Kazuomi Nishida, Naoshi Hagiwara, Satoru et al.

Source: Cancers. Dec2025, Vol. 17 Issue 23, p3826. 14p.

Utility of Serum HBV RNA Measurement During Nucleoside/Nucleotide Analog Therapy in Chronic Hepatitis B Patients.

Authors: Hiraoka, Keiichi Tsuge, Masataka Kawahara, Michihiko et al.

Source: International Journal of Molecular Sciences. Oct2025, Vol. 26 Issue 20, p10141. 14p.